CCA
GSK icon

Checchi Capital Advisers’s GSK GSK Stock Holding History

Checchi Capital Advisers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Sell
11,715
-235
-2% -$12.4K 0.03% 316
2026
Q1 		$660K Buy
11,950
+130
+1% +$7.04K 0.03% 291
2025
Q4 		$580K Buy
11,820
+234
+2% +$10.9K 0.03% 287
2025
Q3 		$500K Buy
11,586
+673
+6% +$26.3K 0.03% 326
2025
Q2 		$419K Sell
10,913
-903
-8% -$34.5K 0.02% 372
2025
Q1 		$458K Sell
11,816
-69
-0.6% -$2.53K 0.02% 352
2024
Q4 		$402K Buy
11,885
+440
+4% +$15.8K 0.02% 370
2024
Q3 		$468K Buy
11,445
+382
+3% +$15.6K 0.03% 346
2024
Q2 		$426K Sell
11,063
-445
-4% -$18.7K 0.02% 355
2024
Q1 		$493K Buy
11,508
+941
+9% +$38.8K 0.04% 327
2023
Q4 		$392K Sell
10,567
-1,081
-9% -$38.8K 0.03% 365
2023
Q3 		$422K Buy
11,648
+740
+7% +$26.3K 0.04% 327
2023
Q2 		$389K Buy
10,908
+1,824
+20% +$65.4K 0.03% 348
2023
Q1 		$323K Buy
9,084
+16
+0.2% +$560 0.03% 388
2022
Q4 		$319K Sell
9,068
-3,206
-26% -$107K 0.03% 375
2022
Q3 		$361K Buy
+12,274
New +$465K 0.03% 333
2022
Q2 		– Sell
-12,272
Closed -$668K – 596
2022
Q1 		$668K Buy
12,272
+390
+3% +$21.2K 0.06% 221
2021
Q4 		$655K Buy
11,882
+225
+2% +$11.7K 0.06% 205
2021
Q3 		$557K Buy
11,657
+6
+0.1% +$301 0.06% 224
2021
Q2 		$580K Sell
11,651
-936
-7% -$45K 0.06% 226
2021
Q1 		$562K Buy
12,587
+137
+1% +$6.22K 0.06% 223
2020
Q4 		$573K Sell
12,450
-1,508
-11% -$69.3K 0.06% 210
2020
Q3 		$657K Buy
13,958
+588
+4% +$29.5K 0.07% 168
2020
Q2 		$682K Sell
13,370
-4
-0% -$205 0.08% 159
2020
Q1 		$633K Buy
13,374
+1,693
+14% +$90.3K 0.06% 139
2019
Q4 		$686K Buy
11,681
+532
+5% +$29.6K 0.09% 153
2019
Q3 		$595K Sell
11,149
-268
-2% -$13.8K 0.08% 166
2019
Q2 		$571K Sell
11,417
-480
-4% -$24.1K 0.07% 172
2019
Q1 		$621K Buy
11,897
+2,031
+21% +$101K 0.07% 157
2018
Q4 		$471K Sell
9,866
-9,424
-49% -$464K 0.06% 176
2018
Q3 		$969K Sell
19,290
-1,508
-7% -$76.6K 0.11% 120
2018
Q2 		$1.05M Buy
20,798
+3,521
+20% +$177K 0.13% 100
2018
Q1 		$844K Buy
17,277
+638
+4% +$29.7K 0.11% 119
2017
Q4 		$738K Sell
16,639
-2,777
-14% -$128K 0.1% 138
2017
Q3 		$985K Sell
19,416
-4,575
-19% -$232K 0.1% 95
2017
Q2 		$1.29M Buy
23,991
+844
+4% +$45K 0.14% 79
2017
Q1 		$1.22M Buy
23,147
+1,704
+8% +$86.4K 0.14% 79
2016
Q4 		$1.03M Sell
21,443
-1,715
-7% -$84.7K 0.14% 83
2016
Q3 		$1.25M Buy
23,158
+272
+1% +$14.9K 0.14% 76
2016
Q2 		$1.24M Buy
22,886
+357
+2% +$18.8K 0.14% 73
2016
Q1 		$1.14M Buy
22,529
+451
+2% +$22.5K 0.25% 78
2015
Q4 		$1.11M Buy
22,078
+554
+3% +$28.2K 0.28% 76
2015
Q3 		$1.03M Buy
21,524
+1,364
+7% +$71K 0.28% 73
2015
Q2 		$1.05M Buy
20,160
+1,066
+6% +$60K 0.28% 68
2015
Q1 		$1.1M Buy
19,094
+2,779
+17% +$159K 0.33% 65
2014
Q4 		$872K Buy
16,315
+53
+0.3% +$2.96K 0.33% 68
2014
Q3 		$934K Buy
16,262
+759
+5% +$46.5K 0.38% 59
2014
Q2 		$1.04M Buy
15,503
+1,307
+9% +$88.5K 0.47% 46
2014
Q1 		$948K Buy
14,196
+9,007
+174% +$609K 0.58% 43
2013
Q4 		$346K Buy
+5,189
New +$336K 0.27% 79

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Checchi Capital Advisers's GSK Position: Q2 2026 in Review

Checchi Capital Advisers reduced its GSK (GSK) stake by 2% in Q2 2026, selling an estimated $12.4K and leaving 11,715 shares worth $614K. The position accounts for 0.03% of the portfolio, ranked #316.

Checchi Capital Advisers first reported a position in GSK in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.29M in Q2 2017. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Checchi Capital Advisers held 11,715 shares of GSK worth $614K as of Q2 2026.
  • Checchi Capital Advisers sold 235 GSK shares in Q2 2026, an estimated $12.4K.
  • GSK made up 0.03% of Checchi Capital Advisers's portfolio in Q2 2026, its #316 holding.
  • Checchi Capital Advisers first reported a position in GSK in Q4 2013 and has held it in 50 quarters since.
  • Checchi Capital Advisers's GSK position peaked at $1.29M in Q2 2017.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.